CAS No. 2754408-94-9
Batch:
Purity:99.20
Chemical Structure
Check the
Claturafenib (PF-07799933)
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
Chemical Information
| IUPAC Name | N-[2-chloro-3-[(5-chloro-3-methyl-4-oxoquinazolin-6-yl)amino]-4-fluorophenyl]-3-fluoroazetidine-1-sulfonamide | |
|---|---|---|
| CAS Number | 2754408-94-9 | |
| Molecular Formula |
C18H15Cl2F2N5O3S |
|
| Molecular Weight (MW) | 490.31 | |
| InChIKey | SHENFUUACGRLOZ-UHFFFAOYSA-N |
Biological Activity
Claturafenib (PF-07799933) is a brain-penetrant, selective, pan-mutant inhibitor of BRAF kinase. By target-specific binding, it suppresses constitutive MAPK/ERK signaling pathway activation, leading to decreased levels of phosphorylated ERK. This downstream cascade disruption effectively inhibits tumor cell proliferation and exhibits potent antitumor activity against both BRAF V600-mutant and non-V600-mutant oncogenic phenotypes in cancer models. [1][2]
How to Prepare Stock Solution?
|
Concentration
Volume
Mass
|
|---|
Solubility
Batch:
All in vitro solubility values are batch-tested experimental data (non-literature values).
| Solvent | Solubility & Note |
|---|---|
| DMSO |
98 mg/mL
(199.87 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
Q: Why does a DMSO stock precipitate in media/saline?
A: It is caused by unheated aqueous media (supersaturation), local solvent shock, or incorrect mixing sequence.
How to fix it?
- Preheat media/saline to 37°C.
- Mix rapidly (pipette/vortex) upon addition.
- For complex mixes, always add the aqueous phase last.
- Re-dissolve minor precipitates with a 37°C water bath and sonication (≤30 min).

Pre-aliquoted for Longevity: Solid-state aliquots offer longer shelf life compared to stock solutions.
Looking for a specific aliquot size? Contact your local sales representative or orders@selleckchem.com.
Reference
Jump to
- Claturafenib (PF-07799933) Clinical Trials
- Claturafenib (PF-07799933) Solubility in DMSO
- Claturafenib (PF-07799933) Stock Solution
- Claturafenib (PF-07799933) Storage
- Claturafenib (PF-07799933) Stability
- Claturafenib (PF-07799933) Molecular Weight
- Claturafenib (PF-07799933) Chemical Structure (2D and 3D)
- Claturafenib (PF-07799933) SDS|MSDS
Note: Technical data last updated: Sep 1, 2026.